Enzon Pharmaceuticals, Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was USD 52,000 compared to USD 207,000 a year ago. Operating loss was USD 1.305 million compared to USD 973,000 a year ago. Net loss was USD 1.311 million compared to USD 979,000 a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.